Therefore, anesthesiologists must consider individual patient factors and medical history, the type of GLP-1 RAs used, the dosing regimen (daily vs. weekly), the duration of GLP-1 RAs use, the indication of use (diabetes mellitus vs. weight loss), coexisting medical diseases, and last but not least, the opinion of the patient. The gene discussed is GCG; the disease is diabetes mellitus.